Lilly Endowment Inc
13F filer · CIK 0000316011Reported Jul 23, 2026
Net seller this quarter
13F portfolio value$108.4BU.S. long equity reported on 13F
Positions10 new · 0 closed
Net flow last quarter-$1.82BBuys minus sells
Top 10 positions weight100.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 23, 20261 positions | |||||
| $108.4B | 100.00% | 9.60% | -1.7% | Q2 2013 | |
| Q1 2026Reported Apr 20, 20261 positions | |||||
| $84.5B | 100.00% | 9.74% | -0.3% | Q2 2013 | |
| Q4 2025Reported Jan 23, 20261 positions | |||||
| $99.1B | 100.00% | 9.75% | -3.5% | Q2 2013 | |
| Q3 2025Reported Oct 31, 20251 positions | |||||
| $72.9B | 100.00% | 10.09% | -0.6% | Q2 2013 | |
Premium opens every quarter this fund has filed